Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012
- PMID: 27050095
- PMCID: PMC4822775
- DOI: 10.1371/journal.pone.0152208
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012
Abstract
Background: Respiratory syncytial virus (RSV) causes significant pediatric morbidity and is the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US infants from 2000‒2009; however, rates in infants at high risk for RSV have not been described. This study examined RSV and unspecified bronchiolitis (UB) hospitalization rates from 1997‒2012 among US high-risk infants.
Methods: The Kids' Inpatient Database (KID) infant annual RSV (ICD-9 079.6, 466.11, 480.1) and UB (ICD-9 466.19, 466.1) hospitalization rates were estimated using weighted counts. Denominators were based on birth hospitalizations with conditions associated with high-risk for RSV: chronic perinatal respiratory disease (chronic lung disease [CLD]); congenital airway anomalies (CAA); congenital heart disease (CHD); Down syndrome (DS); and other genetic, metabolic, musculoskeletal, and immunodeficiency conditions. Preterm infants could not be identified. Hospitalizations were characterized by mechanical ventilation, inpatient mortality, length of stay, and total cost (2015$). Poisson and linear regression were used to test statistical significance of trends.
Results: RSV and UB hospitalization rates were substantially elevated for infants with higher-risk CHD, CLD, CAA and DS without CHD compared with all infants. RSV rates declined by 47.0% in CLD and 49.7% in higher-risk CHD infants; no other declines in high-risk groups were observed. UB rates increased in all high-risk groups except for a 22.5% decrease among higher-risk CHD. Among high-risk infants, mechanical ventilation increased through 2012 to 20.4% and 13.5% of RSV and UB hospitalizations; geometric mean cost increased to $31,742 and $25,962, respectively, and RSV mortality declined to 0.9%.
Conclusions: Among high-risk infants between 1997 and 2012, RSV hospitalization rates declined among CLD and higher-risk CHD infants, coincident with widespread RSV immunoprophylaxis use in these populations. UB hospitalization rates increased in all high-risk groups except higher-risk CHD, suggesting improvement in the health status of higher-risk CHD infants, potentially due to enhanced surgical interventions. Mechanical ventilation use and RSV and UB hospitalization costs increased while RSV mortality declined.
Conflict of interest statement
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822775/bin/pone.0152208.g001.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822775/bin/pone.0152208.g002.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4822775/bin/pone.0152208.g003.gif)
Similar articles
-
Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations.PLoS One. 2018 Oct 31;13(10):e0205399. doi: 10.1371/journal.pone.0205399. eCollection 2018. PLoS One. 2018. PMID: 30379957 Free PMC article.
-
Respiratory syncytial virus prophylaxis and the "special population".Minerva Pediatr. 2018 Dec;70(6):589-599. doi: 10.23736/S0026-4946.18.05316-1. Epub 2018 Oct 18. Minerva Pediatr. 2018. PMID: 30334623 Review.
-
Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.PLoS One. 2017 Mar 2;12(3):e0172512. doi: 10.1371/journal.pone.0172512. eCollection 2017. PLoS One. 2017. PMID: 28253361 Free PMC article.
-
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4. J Perinatol. 2016. PMID: 27490190 Free PMC article.
-
Special populations.Paediatr Respir Rev. 2009 Jun;10 Suppl 1:21-2. doi: 10.1016/S1526-0542(09)70010-7. Paediatr Respir Rev. 2009. PMID: 19651396 Review.
Cited by
-
High-flow nasal cannula therapy for infants with bronchiolitis.Cochrane Database Syst Rev. 2024 Mar 20;3(3):CD009609. doi: 10.1002/14651858.CD009609.pub3. Cochrane Database Syst Rev. 2024. PMID: 38506440 Review.
-
Epidemiology and Risk Factor Analysis of Children with Bronchiolitis Admitted to the Intensive Care Unit at a Tertiary Care Center in Saudi Arabia.Children (Basel). 2023 Mar 30;10(4):646. doi: 10.3390/children10040646. Children (Basel). 2023. PMID: 37189894 Free PMC article.
-
Respiratory Syncytial Virus in Veneto Region: Analysis of Hospital Discharge Records from 2007 to 2021.Int J Environ Res Public Health. 2023 Mar 4;20(5):4565. doi: 10.3390/ijerph20054565. Int J Environ Res Public Health. 2023. PMID: 36901576 Free PMC article.
-
Respiratory syncytial virus reinfections among infants and young children in the United States, 2011-2019.PLoS One. 2023 Feb 16;18(2):e0281555. doi: 10.1371/journal.pone.0281555. eCollection 2023. PLoS One. 2023. PMID: 36795639 Free PMC article.
-
Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019.J Infect Dis. 2022 Aug 15;226(Suppl 2):S184-S194. doi: 10.1093/infdis/jiac155. J Infect Dis. 2022. PMID: 35968879 Free PMC article.
References
-
- Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22(10):857–62. - PubMed
-
- Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344(25):1917–28. - PubMed
-
- Centers for Disease Control and Prevention. RSV: infection and incidence 2008 [cited 2009 September 18]. Available: http://www.cdc.gov/rsv/about/infection.html. Accessed 18 September 2009.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical